Replies to post #249609 on Biotech Values

[xavierprivas]

I bought PHAT in January and sold it in August this year. Made a good profit but I bought some other names that are now at a loss.
This market for proton pump inhibitor is huge. Takeda does 800M in Japan from this drug.
I would buy it back at this price except I have no more money.